Nuvation Bio Stock Investor Sentiment

NUVB Stock  USD 2.14  0.07  3.17%   
About 64% of all Nuvation Bio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Nuvation Bio suggests that some traders are interested. The current market sentiment, together with Nuvation Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Nuvation Bio stock news signals to limit their universe of possible portfolio assets.
  

Nuvation Bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Nuvation Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
58.0%
57.1%
55.4%
57.1%
54.4%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Nuvation Bio Maximum Pain Price Across June 20th 2025 Option Contracts

Nuvation Bio's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Nuvation Bio close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Nuvation Bio's options.
Calls PricePuts Price
16 hours ago at www.macroaxis.com         
Acquisition by Cui Xiangmin of 967100 shares of Nuvation Bio subject to Rule 16b-3
Macroaxis News
2 days ago at thelincolnianonline.com         
Nuvation Bio Shares Down 2.5 percent Time to Sell?
news
few days ago at news.google.com         
Jones Trading sets 10 target for Nuvation Bio stock with Buy rating - Investing.com
Google News at Macroaxis
few days ago at news.google.com         
Q1 Earnings Estimate for Nuvation Bio Issued By Wedbush - Defense World
Google News at Macroaxis
six days ago at finance.yahoo.com         
Nuvation Bio Inc. Among the Best NYSE Penny Stocks to Buy According to Analysts
Yahoo News
over a week ago at www.macroaxis.com         
Acquisition by Kathryn Falberg of 43000 shares of Nuvation Bio at 1.9526 subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
Nuvation Bio Reports Transformative Year in 2024 - TipRanks
Google News at Macroaxis
over a week ago at businesswire.com         
Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updat...
businesswire News
over a week ago at gurufocus.com         
Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business ...
Gurufocus Stories at Macroaxis
over a week ago at seekingalpha.com         
Nuvation Bio GAAP EPS of -0.15 misses by 0.01, revenue of 5.71M
seekingalpha News
over a week ago at thelincolnianonline.com         
Nuvation Bio Receives Outperform Rating from Wedbush
news
over a week ago at kalkinemedia.com         
How Has Nuvation Bio Positioned Itself in the Oncology Market?
news
over a week ago at kalkinemedia.com         
Acquisition by Gary Hattersley of 500000 shares of Nuvation Bio at 1.97 subject to Rule 16b-3
news
over a week ago at finance.yahoo.com         
Nuvation Bio Secures Up to 250 Million in Non-Dilutive Financings from Sagard Healthcare Partners
Yahoo News
over a week ago at gurufocus.com         
Nuvation Bio Secures Up to 250 Million in Non-Dilutive Financings from Sagard Healthcare Partners
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Nuvation Bio that are available to investors today. That information is available publicly through Nuvation media outlets and privately through word of mouth or via Nuvation internal channels. However, regardless of the origin, that massive amount of Nuvation data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nuvation Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nuvation Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nuvation Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nuvation Bio alpha.

Nuvation Bio Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.151234567891011Dec2025FebMar -30-20-10010
JavaScript chart by amCharts 3.21.15Nuvation Bio Nuvation Bio Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
01/06/2025
2
Clinical-Stage Progress at Nuvation Bio Reflects Strategic Growth
01/27/2025
3
Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer
02/03/2025
4
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
02/18/2025
5
Acquisition by Junyuan Wang of 1695700 shares of Nuvation Bio subject to Rule 16b-3
02/25/2025
6
Which Emerging Biopharma Firm Excels in Oncology and Brain Treatments
02/27/2025
7
Acquisition by Stacy Markel of 500000 shares of Nuvation Bio at 1.94 subject to Rule 16b-3
02/28/2025
8
Nuvation Bio Secures Up to 250 Million in Non-Dilutive Financings from Sagard Healthcare Partners
03/03/2025
9
Nuvation Bio Receives Outperform Rating from Wedbush
03/06/2025
10
Acquisition by Kathryn Falberg of 43000 shares of Nuvation Bio at 1.9526 subject to Rule 16b-3
03/07/2025
11
Nuvation Bio Shares Down 2.5 percent Time to Sell
03/14/2025

Complementary Tools for Nuvation Stock analysis

When running Nuvation Bio's price analysis, check to measure Nuvation Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvation Bio is operating at the current time. Most of Nuvation Bio's value examination focuses on studying past and present price action to predict the probability of Nuvation Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvation Bio's price. Additionally, you may evaluate how the addition of Nuvation Bio to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
News Freq…Investor S…